Adamis Pharmaceuticals

ADMP

5.25

+0.05

+1.0%

After Hours:

5.25

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 5.20
Prev. Close: 5.20
Low/Hi: 5.10 - 5.35
52-Week: 2.40 - 6.45
Volumes
Equity: 649,577
90-Day Avg: 1,077,370
Option: 705
90-Day Avg: 1,845
Volatility
Todays Stock Vol: 43.9
20-Day (HV): 51.3
52-Week (HV): 68.9
30-Day IV: 67.5 +1.5
IV Pct Rank: 21% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 10-Nov (Est.)
P/E Ratio:
Market Cap: 163.0 M
Stock Type: Common
Sector: Healthcare
Industry: Drug Delivery
Stock Type: Common | Sector: Healthcare | Industry: Drug Delivery

ADMP Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -4,971 -5,773 -670 -8,018
Change in Working Capital -780 78 11 -2,194
Depreciation Amortization Depletion and Accretion 778 783 783 785
Deferred Taxes 0 0 -4,587 0
Other Non-Cash Activities 1,500 1,403 1,177 1,313
Total Cash from Operating Activities -3,474 -3,509 -3,286 -6,740
Capital Expenditures -568 -64 -104 0
Other Investing Cash Flow 0 0 0 0
Total Cash from Investing Activities -568 -64 -104 0
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 16,357 0 0 15,134
Purchase and Retirement of Debt -1,981 -115 -325 0
Other Financing Cash Flow 0 0 1,000 -1,000
Total Cash from Financing Activities 14,377 -115 675 14,134
Exchange Rate Effects 0 0 0 0
Net Change in Cash 10,335 -3,688 -2,715 7,393
Period Ending 31-Dec-2016 31-Dec-2015 31-Mar-2014
Net Income -20,811 -13,572 -8,156
Change in Working Capital -3,107 14 -2,120
Depreciation Amortization Depletion and Accretion 2,535 990 7,765
Deferred Taxes -4,587 0 0
Other Non-Cash Activities 3,437 2,233 -4,270
Total Cash from Operating Activities -21,160 -10,336 -6,780
Capital Expenditures -121 0 -10,000
Other Investing Cash Flow 382 0 0
Total Cash from Investing Activities 261 0 -10,000
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 20,239 10,642 25,454
Purchase and Retirement of Debt 1,675 0 -1,061
Other Financing Cash Flow 0 0 -2,210
Total Cash from Financing Activities 21,915 10,642 22,183
Exchange Rate Effects 0 0 0
Net Change in Cash 1,015 306 5,403